JP2016534984A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534984A5 JP2016534984A5 JP2016519325A JP2016519325A JP2016534984A5 JP 2016534984 A5 JP2016534984 A5 JP 2016534984A5 JP 2016519325 A JP2016519325 A JP 2016519325A JP 2016519325 A JP2016519325 A JP 2016519325A JP 2016534984 A5 JP2016534984 A5 JP 2016534984A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- heteroaryl
- aryl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052757 nitrogen Inorganic materials 0.000 claims 48
- 229910052760 oxygen Inorganic materials 0.000 claims 46
- 125000001072 heteroaryl group Chemical group 0.000 claims 43
- 125000003118 aryl group Chemical group 0.000 claims 41
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 33
- 125000000753 cycloalkyl group Chemical group 0.000 claims 33
- 229910052717 sulfur Inorganic materials 0.000 claims 30
- 150000001875 compounds Chemical class 0.000 claims 24
- 150000003839 salts Chemical class 0.000 claims 19
- 150000001409 amidines Chemical class 0.000 claims 12
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 claims 12
- -1 or N Inorganic materials 0.000 claims 10
- 125000001544 thienyl group Chemical group 0.000 claims 4
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims 3
- 125000004404 heteroalkyl group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000002785 azepinyl group Chemical group 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 125000002971 oxazolyl group Chemical group 0.000 claims 2
- 125000003585 oxepinyl group Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 2
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000003944 tolyl group Chemical group 0.000 claims 2
- 125000005023 xylyl group Chemical group 0.000 claims 2
- FRVQGCBWBSJTQC-UHFFFAOYSA-N CCc1nc(sc1C(=O)NCCOCCOCCN)N1CCC(CC1)C1CCN(CC1)C(=O)c1ccc(cc1)-c1nc2ccccc2[nH]1 Chemical compound CCc1nc(sc1C(=O)NCCOCCOCCN)N1CCC(CC1)C1CCN(CC1)C(=O)c1ccc(cc1)-c1nc2ccccc2[nH]1 FRVQGCBWBSJTQC-UHFFFAOYSA-N 0.000 claims 1
- ZFOFFCQSWVUJAX-UHFFFAOYSA-N NCCOCCOCCNC(=O)c1ccc2nc([nH]c2c1)-c1ccccc1 Chemical compound NCCOCCOCCNC(=O)c1ccc2nc([nH]c2c1)-c1ccccc1 ZFOFFCQSWVUJAX-UHFFFAOYSA-N 0.000 claims 1
- 241000534944 Thia Species 0.000 claims 1
- 238000001042 affinity chromatography Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- GGNIKGLUPSHSBV-UHFFFAOYSA-N thiazole-5-carboxamide Chemical compound NC(=O)C1=CN=CS1 GGNIKGLUPSHSBV-UHFFFAOYSA-N 0.000 claims 1
- 0 *NC(c1cccc(NC(OC(CC2)CCN2C(c2ccc(*=*(*3)c4ccccc4)c3c2)=O)=O)c1)=O Chemical compound *NC(c1cccc(NC(OC(CC2)CCN2C(c2ccc(*=*(*3)c4ccccc4)c3c2)=O)=O)c1)=O 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361885146P | 2013-10-01 | 2013-10-01 | |
| US61/885,146 | 2013-10-01 | ||
| US201462025994P | 2014-07-17 | 2014-07-17 | |
| US62/025,994 | 2014-07-17 | ||
| PCT/IB2014/064998 WO2015049651A1 (en) | 2013-10-01 | 2014-10-01 | Compounds for affinity chromatography and for extending the half-life of a therapeutic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016534984A JP2016534984A (ja) | 2016-11-10 |
| JP2016534984A5 true JP2016534984A5 (enExample) | 2017-11-16 |
Family
ID=51743521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016519325A Pending JP2016534984A (ja) | 2013-10-01 | 2014-10-01 | アフィニティークロマトグラフィーのためおよび治療薬の半減期の延長のための化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9809558B2 (enExample) |
| EP (1) | EP3052483B1 (enExample) |
| JP (1) | JP2016534984A (enExample) |
| KR (1) | KR20160060660A (enExample) |
| CN (1) | CN105593222B (enExample) |
| AU (1) | AU2014330781B2 (enExample) |
| BR (1) | BR112016007371A2 (enExample) |
| CA (1) | CA2925862A1 (enExample) |
| ES (1) | ES2721098T3 (enExample) |
| RU (1) | RU2016117052A (enExample) |
| SG (1) | SG11201601870VA (enExample) |
| WO (1) | WO2015049651A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10697982B2 (en) | 2015-09-08 | 2020-06-30 | Merck Patent Gmbh | Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies |
| US20170066839A1 (en) | 2015-09-08 | 2017-03-09 | Merck Patent Gmbh | Novel affinity chromatography media for removal of anti-a and/or anti-b antibodies |
| US10697983B2 (en) | 2015-09-08 | 2020-06-30 | Merck Patent Gmbh | Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies |
| JPWO2018181738A1 (ja) * | 2017-03-30 | 2020-02-13 | 日立化成株式会社 | 分離材 |
| EP3887386A4 (en) * | 2018-11-26 | 2022-11-30 | North Carolina State University | PEPTIDE LIGANDS FOR CAPTURE OF HOST CELL PROTEINS |
| US20220153853A1 (en) | 2018-12-21 | 2022-05-19 | Jiangsu Hengrui Medicine Co., Ltd. | Bispecific protein |
| PH12022551379A1 (en) | 2019-12-06 | 2023-05-03 | Vertex Pharma | Substituted tetrahydrofurans as modulators of sodium channels |
| SI4347031T1 (sl) | 2021-06-04 | 2026-01-30 | Vertex Pharmaceuticals Incorporated | N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov |
| MX2023014754A (es) | 2021-06-18 | 2024-02-12 | Aligos Therapeutics Inc | Métodos y composiciones dirigidos a pd-l1. |
| CN119212987A (zh) | 2021-12-16 | 2024-12-27 | 安力高医药股份有限公司 | 用于靶向pd-l1的方法和组合物 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH187973A4 (de) * | 1973-02-09 | 1977-03-31 | Hoechst Ag | Verfahren zum optischen Aufhellen von Textilmaterialien |
| US4722896A (en) | 1981-01-26 | 1988-02-02 | The Beth Israel Hospital Association | Method for affinity purification of hybridoma antibodies |
| US5849874A (en) | 1991-07-12 | 1998-12-15 | Gist-Brocades, N.V. | Process for the purification of serum albumin |
| JP2825755B2 (ja) * | 1993-04-07 | 1998-11-18 | 大塚製薬株式会社 | ピペリジン誘導体を有効成分とする末梢血管拡張剤および新規ピペリジン誘導体 |
| JPH09511492A (ja) * | 1994-02-03 | 1997-11-18 | ザ ピコワー インスティテュート フォア メディカル リサーチ | アミロイドーシスの前進性グリコシル化終末産物仲介モジュレーション用組成物及び方法 |
| GB9914825D0 (en) * | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
| CZ20013424A3 (cs) | 1999-12-27 | 2002-02-13 | Japan Tobacco Inc. | Sloučeniny s fúzovanými kruhy a jejich pouľití jako léčiva |
| DE10139416A1 (de) * | 2001-08-17 | 2003-03-06 | Aventis Pharma Gmbh | Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| GB2403222A (en) | 2002-04-01 | 2004-12-29 | Utah Ventures Ii L P | Tissue-specific endothelial membrane proteins |
| CA2494139A1 (en) * | 2002-08-02 | 2004-02-12 | Genesoft Pharmaceuticals, Inc. | Biaryl compounds having anti-infective activity |
| US7777051B2 (en) | 2003-05-13 | 2010-08-17 | Icagen, Inc. | Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| US8629147B2 (en) | 2005-11-03 | 2014-01-14 | Chembridge Corporation | Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| LT2459220T (lt) | 2009-07-31 | 2020-12-28 | Ascendis Pharma A/S | Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu |
| EP2491009B1 (en) * | 2009-10-19 | 2017-07-05 | Boehringer Ingelheim International GmbH | Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
| WO2012017021A2 (en) | 2010-08-03 | 2012-02-09 | Graffinity Pharmaceuticals Gmbh | LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY |
| WO2012020080A2 (en) | 2010-08-12 | 2012-02-16 | Graffinity Pharmaceuticals Gmbh | LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY II |
| WO2012140647A2 (en) | 2011-04-11 | 2012-10-18 | Yeda Research And Development Co. Ltd | Albumin binding probes and drug conjugates thereof |
| UA115576C2 (uk) | 2012-12-06 | 2017-11-27 | Байєр Фарма Акцієнгезелльшафт | Похідні бензимідазолу як антагоністи ер4 |
| EP2752426A1 (en) | 2013-01-03 | 2014-07-09 | Covagen AG | Human serum albumin binding compounds and fusion proteins thereof |
-
2014
- 2014-10-01 RU RU2016117052A patent/RU2016117052A/ru not_active Application Discontinuation
- 2014-10-01 US US15/026,725 patent/US9809558B2/en not_active Expired - Fee Related
- 2014-10-01 WO PCT/IB2014/064998 patent/WO2015049651A1/en not_active Ceased
- 2014-10-01 BR BR112016007371A patent/BR112016007371A2/pt not_active Application Discontinuation
- 2014-10-01 KR KR1020167008267A patent/KR20160060660A/ko not_active Withdrawn
- 2014-10-01 CA CA2925862A patent/CA2925862A1/en not_active Abandoned
- 2014-10-01 JP JP2016519325A patent/JP2016534984A/ja active Pending
- 2014-10-01 ES ES14786355T patent/ES2721098T3/es active Active
- 2014-10-01 CN CN201480054551.4A patent/CN105593222B/zh not_active Expired - Fee Related
- 2014-10-01 SG SG11201601870VA patent/SG11201601870VA/en unknown
- 2014-10-01 AU AU2014330781A patent/AU2014330781B2/en not_active Ceased
- 2014-10-01 EP EP14786355.9A patent/EP3052483B1/en active Active
-
2017
- 2017-09-07 US US15/698,020 patent/US9938243B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016117052A (ru) | Соединения для аффинной хроматографии и для продления времени полужизни терапевтического средства | |
| JP2023514872A5 (enExample) | ||
| JP2006524222A5 (enExample) | ||
| JP2013517283A5 (enExample) | ||
| PE20090297A1 (es) | Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogenesis | |
| JP2014511869A5 (enExample) | ||
| JP2008516986A5 (enExample) | ||
| JP2012502974A5 (enExample) | ||
| AR089134A1 (es) | Arilos y heteroarilos biciclicos inhibidores de los canales de sodio | |
| JP2016053042A5 (enExample) | ||
| JP2010506825A5 (enExample) | ||
| JP2016540742A5 (enExample) | ||
| JP2011524422A5 (enExample) | ||
| JP2010540462A5 (enExample) | ||
| JP2007530459A5 (enExample) | ||
| JP2016503009A5 (enExample) | ||
| JP2007519695A5 (enExample) | ||
| PE20141375A1 (es) | Activadores de glucoquinasa | |
| PE20081530A1 (es) | Nuevos compuestos 617 | |
| JP2016505614A5 (enExample) | ||
| RU2015127822A (ru) | Ингибиторы энхансера гомолога 2 белка zeste | |
| JP2017518344A5 (enExample) | ||
| RU2018109925A (ru) | Галогензамещенное гетероциклическое соединение | |
| JP2016540811A5 (enExample) | ||
| RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 |